Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Toxicology
|
May 7, 1998
Formation of zinc protoporphyrin in cultured hepatocytes: effects of ferrochelatase inhibition, iron chelation or lead
J M Jacobs, P R Sinclair, J F Sinclair, et al.
Biochemical Pharmacology
|
July 28, 1999
Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice
N Gorman, H S Walton, W J Bement, et al.
Biochemical Pharmacology
|
March 29, 2001
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant mice
C Zaccaro, S Sweitzer, S Pipino, et al.
The Journal of Laboratory and Clinical Medicine
|
August 1, 1997
Ascorbic acid deficiency in porphyria cutanea tarda
P R Sinclair, N Gorman, S I Shedlofsky, et al.
Analytical Biochemistry
|
May 15, 1986
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials
H L Bonkovsky, S G Wood, S K Howell, et al.
Archives of Biochemistry and Biophysics
|
January 1, 1993
In vivo fate of hemopexin and heme-hemopexin complexes in the rat
D Potter, Z C Chroneos, J W Baynes, et al.
The Biochemical Journal
|
April 16, 1998
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice
P R Sinclair, N Gorman, T Dalton, et al.
Toxicology and Applied Pharmacology
|
January 13, 2000
CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron
P R Sinclair, N Gorman, H S Walton, et al.
The Biochemical Journal
|
July 15, 1988
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid
A J Urquhart, G H Elder, A G Roberts, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1994
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytes
P R Sinclair, W J Bement, J F Healey, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Toxicology
|
May 7, 1998
Formation of zinc protoporphyrin in cultured hepatocytes: effects of ferrochelatase inhibition, iron chelation or lead
J M Jacobs, P R Sinclair, J F Sinclair, et al.
Biochemical Pharmacology
|
July 28, 1999
Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice
N Gorman, H S Walton, W J Bement, et al.
Biochemical Pharmacology
|
March 29, 2001
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant mice
C Zaccaro, S Sweitzer, S Pipino, et al.
The Journal of Laboratory and Clinical Medicine
|
August 1, 1997
Ascorbic acid deficiency in porphyria cutanea tarda
P R Sinclair, N Gorman, S I Shedlofsky, et al.
Analytical Biochemistry
|
May 15, 1986
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials
H L Bonkovsky, S G Wood, S K Howell, et al.
Archives of Biochemistry and Biophysics
|
January 1, 1993
In vivo fate of hemopexin and heme-hemopexin complexes in the rat
D Potter, Z C Chroneos, J W Baynes, et al.
The Biochemical Journal
|
April 16, 1998
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice
P R Sinclair, N Gorman, T Dalton, et al.
Toxicology and Applied Pharmacology
|
January 13, 2000
CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron
P R Sinclair, N Gorman, H S Walton, et al.
The Biochemical Journal
|
July 15, 1988
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid
A J Urquhart, G H Elder, A G Roberts, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1994
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytes
P R Sinclair, W J Bement, J F Healey, et al.
Page
of 11